Sichuan Huiyu Pharmaceutical Co., Ltd.
SSE:688553.SS
16.09 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 315.897 | 139.786 | 248.991 | 445.859 | 341.823 | 176.909 | -22.005 | -84.718 |
| Depreciation & Amortization
| 79.838 | 63.877 | 53.114 | 41.127 | 24.75 | 18.422 | 21.993 | 26.544 |
| Deferred Income Tax
| 0 | -23.902 | -14.409 | -4.11 | 20.23 | 23.254 | -49.326 | 0 |
| Stock Based Compensation
| 0 | 0 | 0.478 | 4.11 | -20.23 | 13.222 | 0 | 0 |
| Change In Working Capital
| 70.542 | -109.846 | -74.221 | -41.464 | 28.488 | 116.575 | 102.133 | 9.613 |
| Accounts Receivables
| -20.265 | -23.936 | -41.608 | -23.857 | -12.894 | -34.183 | 14.368 | 0 |
| Inventory
| -12.876 | 10.56 | 8.952 | -87.038 | -48.718 | -24.677 | -10.261 | -5.776 |
| Accounts Payables
| 0 | -72.568 | -27.156 | 73.541 | 69.87 | 152.18 | 147.352 | 0 |
| Other Working Capital
| 103.684 | -23.902 | -14.409 | -4.11 | 20.23 | 23.254 | 112.393 | 15.39 |
| Other Non Cash Items
| -223.322 | -2.981 | -19.892 | 0.842 | -7.114 | -22.16 | 26.939 | 35.397 |
| Operating Cash Flow
| 242.956 | 66.933 | 194.06 | 446.363 | 387.948 | 326.221 | 129.06 | -13.164 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -128.18 | -296.72 | -461.613 | -433.453 | -158.24 | -110.003 | -23.039 | -7.048 |
| Acquisitions Net
| 0 | 1.039 | 0 | 0.002 | -0 | 110.003 | 23.069 | 0 |
| Purchases Of Investments
| -1,200.015 | -3,629 | -4,973 | -5,740.1 | -4,516 | -744.23 | -38.745 | 0 |
| Sales Maturities Of Investments
| 1,598.554 | 4,123.172 | 5,258.579 | 4,301.429 | 4,449.125 | 575.333 | 31.134 | 0 |
| Other Investing Activites
| 0.099 | 34.856 | -5 | 0 | -0.971 | -110.003 | -23.039 | 5.099 |
| Investing Cash Flow
| 270.457 | 233.348 | -181.034 | -1,872.122 | -226.086 | -278.9 | -30.62 | -1.949 |
| Financing Activities: | ||||||||
| Debt Repayment
| 58.5 | 261.5 | -18.198 | 14.054 | -40 | -164.89 | -30.005 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | -19.234 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 19.234 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -98.136 | -99.509 | -89.38 | -0.69 | -1.875 | -14.147 | -48.857 | -9.88 |
| Other Financing Activities
| -46.664 | -39.693 | 7.588 | 2,333.885 | -7.417 | 344.867 | 21.534 | 13.105 |
| Financing Cash Flow
| -86.299 | 122.298 | -99.99 | 2,347.248 | -49.291 | 165.83 | -57.327 | 3.225 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0.067 | 1.641 | -0.161 | -0.042 | -0.191 | 0.276 | -0.017 | 0.008 |
| Net Change In Cash
| 427.18 | 424.219 | -87.125 | 921.447 | 112.38 | 213.427 | 41.096 | -11.879 |
| Cash At End Of Period
| 2,057.244 | 1,630.064 | 1,205.845 | 1,292.97 | 371.522 | 259.142 | 45.716 | 4.62 |